Omega Healthcare (OHI) Receives a Buy from Berenberg Bank
In a report released on February 20, from Berenberg Bank maintained a Buy rating on Omega Healthcare, with a price target of $53.00. The company’s shares closed last Friday at $46.57.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Omega Healthcare with a $48.11 average price target, implying a 3.31% upside from current levels. In a report released on February 12, TipRanks – Google also reiterated a Buy rating on the stock with a $53.00 price target.
Based on Omega Healthcare’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $321.82 million and a net profit of $164.72 million. In comparison, last year the company earned a revenue of $279.32 million and had a net profit of $113.34 million
Read More on OHI:
Disclaimer & DisclosureReport an Issue
- Omega Healthcare price target raised to $47 from $44 at RBC Capital
- Omega Healthcare price target raised to $52 from $50 at Cantor Fitzgerald
- Omega Healthcare Investors: Rising Operational and Earnings Risk as RIDEA Expansion Increases Dependence on Third-Party Managers
- Omega Healthcare Investors Signals Confident 2026 Earnings Path
- Omega Healthcare price target raised to $52 from $51 at UBS
